ABSTRACT
Medical AI models have made a great impact on biomedical research and real-world clinical applications, but conducting interdisciplinary medical AI research remains challenging, requiring close collaboration between clinicians and AI experts. Recent advances in large language models (LLMs) and autonomous code agents present an opportunity for low cost medical AI development, where clinicians can build AI tailored to their own research questions, even without continuous support from dedicated AI experts. However, enabling code agents to autonomously tackle complex multimodal medical AI development tasks requires clinicians to construct and supervise an AI research loop with detailed technical specifics, demanding substantial expertise in AI and computer science that they often lack. To address this challenge, we introduce the Medical AI Research Loop Agent (MARLA), an agentic framework that completely abstracts the construction and supervision of medical AI research loops from clinicians. Given a clinician-defined research intent, MARLA automatically translates high-level research goals into executable hierarchical research loops, decomposes them into verifiable sub-loops, and specifies the models, datasets, tools, and evaluation protocols required for each task. During execution, MARLA coordinates specialized code agents, monitors progress, diagnoses failures, and iteratively refines research strategies based on experimental feedback to drive the research process toward optimal outcomes. We evaluate MARLA on multimodal medical AI tasks that require closed-loop conversion from high-level clinical study objectives to trained and validated AI models. The results demonstrate MARLA’s ability to autonomously conduct complex medical AI research while substantially reducing the need for AI expertise.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at:TCGA-KIRC, ADNI, MIMIC-IV-MM
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
{2310901{at}tongji.edu.cn}
{xinyangjiang{at}microsoft.com, caihua.shan{at}microsoft.com, wangzilong{at}microsoft.com}
Data Availability
All data produced are available online.
https://portal.gdc.cancer.gov/projects/TCGA-KIRC
https://www.cancerimagingarchive.net/collection/tcga-kirc/
https://adni.loni.usc.edu/data-samples/access-data/
https://physionet.org/content/mimiciv/
https://physionet.org/content/mimic-cxr-jpg/





